Literature DB >> 23199140

The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome.

Anahita Adeli1, Rodolfo Savica, Val J Lowe, Prashanthi Vemuri, David S Knopman, Mariely Dejesus-Hernandez, Rosa Rademakers, Julie A Fields, Brian A Crum, Clifford R Jack, Ronald C Petersen, Bradley F Boeve.   

Abstract

A hexanucleotide repeat expansion in the chromosome 9 open reading frame 72 (C9ORF72) gene was recently discovered as the cause underlying frontotemporal degeneration (FTD) and/or amyotrophic lateral sclerosis (ALS) linked to chromosome 9 (c9FTD/ALS). In this atypical case of c9FTD/ALS, the proband presented with amnestic mild cognitive impairment which evolved into Alzheimer's disease (AD)-type dementia and later developed ALS. Fluorodeoxyglucose-positron emission tomography of the brain demonstrated mild hypometabolism involving the medial frontal and lateral temporal lobes, left more so than right, which progressed over time. He was subsequently confirmed to have the C9ORF72 expansion. This report highlights the need to consider mutations in the FTD-associated genes when a familial disorder is suggested and neuroimaging studies reveal findings atypical of an AD pathophysiological process despite the typical anterograde amnestic syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23199140      PMCID: PMC3593970          DOI: 10.1080/13554794.2012.732090

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  39 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

2.  Mayo's older Americans normative studies: category fluency norms.

Authors:  J A Lucas; R J Ivnik; G E Smith; D L Bohac; E G Tangalos; N R Graff-Radford; R C Petersen
Journal:  J Clin Exp Neuropsychol       Date:  1998-04       Impact factor: 2.475

3.  A short test of mental status: description and preliminary results.

Authors:  E Kokmen; J M Naessens; K P Offord
Journal:  Mayo Clin Proc       Date:  1987-04       Impact factor: 7.616

4.  Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin.

Authors:  Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Maria Shiung; David S Knopman; Rosa Rademakers; Mike Hutton; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Ronald C Petersen
Journal:  Arch Neurol       Date:  2010-02

Review 5.  Current concepts in mild cognitive impairment.

Authors:  R C Petersen; R Doody; A Kurz; R C Mohs; J C Morris; P V Rabins; K Ritchie; M Rossor; L Thal; B Winblad
Journal:  Arch Neurol       Date:  2001-12

6.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22.

Authors:  B A Hosler; T Siddique; P C Sapp; W Sailor; M C Huang; A Hossain; J R Daube; M Nance; C Fan; J Kaplan; W Y Hung; D McKenna-Yasek; J L Haines; M A Pericak-Vance; H R Horvitz; R H Brown
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

7.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

Authors:  G M McKhann; M S Albert; M Grossman; B Miller; D Dickson; J Q Trojanowski
Journal:  Arch Neurol       Date:  2001-11

8.  Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western Europe.

Authors:  R Rademakers; B Dermaut; K Peeters; M Cruts; P Heutink; A Goate; C Van Broeckhoven
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

9.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

10.  Apolipoprotein E: risk factor for Alzheimer disease.

Authors:  M S Tsai; E G Tangalos; R C Petersen; G E Smith; D J Schaid; E Kokmen; R J Ivnik; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more
  4 in total

Review 1.  C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Authors:  Jennifer S Yokoyama; Daniel W Sirkis; Bruce L Miller
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

Review 2.  C9ORF72 mutations in neurodegenerative diseases.

Authors:  Ying Liu; Jin-Tai Yu; Yu Zong; Jing Zhou; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-08-10       Impact factor: 5.590

3.  Phenotypic variability and neuropsychological findings associated with C9orf72 repeat expansions in a Bulgarian dementia cohort.

Authors:  Shima Mehrabian; Håkan Thonberg; Margarita Raycheva; Lena Lilius; Katya Stoyanova; Charlotte Forsell; Lena Cavallin; Desislava Nesheva; Eric Westman; Draga Toncheva; Latchezar Traykov; Bengt Winblad; Caroline Graff
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

Review 4.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.